Zobrazeno 1 - 10
of 315
pro vyhledávání: '"Charles D, Blanke"'
Autor:
Young Kwang Chae, Megan Othus, Sandip Pravin Patel, David E. Gerber, Tawee Tanvetyanon, Hye Sung Kim, Liam Il-Young Chung, Christine M. McLeod, Gabby Lopez, Helen X. Chen, Elad Sharon, Howard Streicher, Cristopher W. Ryan, Charles D. Blanke, Razelle Kurzrock
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Anti-programmed death-1 (PD-1)/cytotoxic T lymphocyte antigen-4 antibodies are efficacious in various malignancies. Objectives: This study presents the first results of ipilimumab–nivolumab in invasive mucinous or non-mucinous lepidic a
Externí odkaz:
https://doaj.org/article/c89726aa1d404f1491a28f4c3b4cc7ad
Autor:
Joseph M. Unger, Michael LeBlanc, Suzanne George, Norman Wolmark, Walter J. Curran, Peter J. O'Dwyer, Mitchell D. Schnall, Robert S. Mannel, Sumithra J. Mandrekar, Robert J. Gray, Fengmin Zhao, Mariama Bah, Riha Vaidya, Charles D. Blanke
Publikováno v:
Journal of Clinical Oncology. 41:2020-2028
PURPOSE In the United States, the National Cancer Institute National Cancer Clinical Trials Network (NCTN) groups have conducted publicly funded oncology research for 50 years. The combined impact of all adult network group trials has never been syst
Autor:
Sepideh Gholami, Sarah Colby, David P. Horowitz, Katherine A. Guthrie, Edgar Ben-Josef, Anthony B. El-Khoueiry, Charles D. Blanke, Philip A. Philip, Lisa A. Kachnic, Syed A. Ahmad, Flavio G. Rocha
Publikováno v:
Annals of Surgical Oncology. 30:1354-1363
Autor:
Nadine J. McCleary, Sui Zhang, Chao Ma, Fang-Shu Ou, Tiffany M. Bainter, Alan P. Venook, Donna Niedzwiecki, Heinz-Josef Lenz, Federico Innocenti, Bert H. O'Neil, Blase N. Polite, Howard S. Hochster, James N. Atkins, Richard M. Goldberg, Kimmie Ng, Robert J. Mayer, Charles D. Blanke, Eileen M. O'Reilly, Charles S. Fuchs, Jeffrey A. Meyerhardt
Publikováno v:
J Geriatr Oncol
BACKGROUND: Little is known about the interaction of comorbidities and age on survival outcomes in colorectal ancer (mCRC), nor how comorbidities impact treatment tolerance. METHODS: We utilized a cohort of 1,345 mCRC patients enrolled in CALGB/SWOG
Autor:
Joseph M. Unger, Riha Vaidya, Kathy S. Albain, Michael LeBlanc, Lori M. Minasian, Carolyn C. Gotay, N. Lynn Henry, Michael J. Fisch, Shing M. Lee, Charles D. Blanke, Dawn L. Hershman
Publikováno v:
Journal of Clinical Oncology. 40:1474-1486
PURPOSE Women have more adverse events (AEs) from chemotherapy than men, but few studies have investigated sex differences in immune or targeted therapies. We examined AEs by sex across different treatment domains. METHODS We analyzed treatment-relat
Autor:
Kimmie Ng, Jeffrey A. Meyerhardt, Charles S. Fuchs, Robert J. Mayer, Alan P. Venook, Richard M. Goldberg, Charles D. Blanke, Heinz-Josef Lenz, Federico Innocenti, Bert H. O'Neil, I-Wen Chang, Fang-Shu Ou, Donna Niedzwiecki, Sui Zhang, Bruce W. Hollis, Kaori Sato, Chen Yuan
Purpose:Previous studies have suggested that higher circulating 25-hydroxyvitamin D [25(OH)D] levels are associated with decreased colorectal cancer risk and improved survival. However, the influence of vitamin D status on disease progression and pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a33078fe2eeb112a327c58260b84968
https://doi.org/10.1158/1078-0432.c.6527921
https://doi.org/10.1158/1078-0432.c.6527921
Autor:
Razelle Kurzrock, Charles D. Blanke, Melissa Plets, Christopher W. Ryan, Edward Mayerson, Elad Sharon, Helen X. Chen, Christine McLeod, Jourdain Hayward, W. Michael Korn, Zoran Gatalica, Marc Matrana, Tareq Al Baghdadi, Anup Kasi, Manisha H. Shah, Annette Fontaine, Preet Paul Singh, Donna E. Hansel, Francis J. Giles, Young Kwang Chae, Megan Othus, Sandip P. Patel
Purpose:Immune checkpoint blockade has improved outcomes across tumor types; little is known about the efficacy of these agents in rare tumors. We report the results of the (nonpancreatic) neuroendocrine neoplasm cohort of SWOG S1609 dual anti–CTLA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1e764ebbb5f97894227c92dd11d1eff
https://doi.org/10.1158/1078-0432.c.6528908
https://doi.org/10.1158/1078-0432.c.6528908
Autor:
Razelle Kurzrock, Young Kwang Chae, Charles D. Blanke, Melissa Plets, Edward Mayerson, Robert J. Gray, Larissa A. Korde, Elad Sharon, Roisin M. Connolly, David D. Biggs, Jane M. Raymond, Olwen Hahn, Frank J. Brescia, Jordi Rodon Ahnert, Hamid R. Mirshahidi, Anne P. O'Dea, Collin T. Zimmerman, Scott A. Anderson, Mridula P. Reddy, Anna Maria V. Storniolo, Barbara J. Haley, Mary D. Chamberlin, Scott M. Schuetze, Rashmi Chugh, Kathy D. Miller, Sandip Pravin Patel, Megan Othus, Sylvia Adams
Supplemental Figure 1: CONSORT Diagram
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c80dc6dec04f0090392e953ac68f745a
https://doi.org/10.1158/1078-0432.22482155
https://doi.org/10.1158/1078-0432.22482155
Autor:
Charles D. Blanke
Gastrointestinal stromal tumors, or GISTs, are now among the most treatable of solid malignancies. Assessing actual tumor response remains challenging; however, in this issue of Clinical Cancer Research, two articles discuss biomarkers potentially he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd006c3c0a8a4b87fdf8d3a2d08e6960
https://doi.org/10.1158/1078-0432.c.6517539
https://doi.org/10.1158/1078-0432.c.6517539
Autor:
Kouros Owzar, Mark J. Ratain, Joel S. Parker, Heinz-Josef Lenz, Michiaki Kubo, Alan P. Venook, Yoichi Furukawa, Charles D. Blanke, James T. Auman, Howard L. McLeod, Monica M. Bertagnolli, Graham Casey, Sarah J. Plummer, Stefanie D. Howell, Fang-Shu Ou, Chen Jiang, Amy S. Etheridge, Sushant A. Patil, Alexander B. Sibley, Federico Innocenti
Supplementary Figures 1-5 and Supplementary Tables 1-5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fcde55a474c729b641c41122fd00e4b
https://doi.org/10.1158/1078-0432.22478180.v1
https://doi.org/10.1158/1078-0432.22478180.v1